AKT1 and renal fibrosis: This study demonstrates that GBXZF administered via colonic dialysis can ameliorate renal fibrosis by repairing the intestinal barrier, reducing LPS and inflammatory factor entry into the bloodstream, and upregulating the PI3K/AKT pathway.